Back to User profile » Professor Xuefeng Kan
Papers published by Professor Xuefeng Kan:
Anti-CD24 Antibody Plus Liposomal Doxorubicin for the Management of Residual Cancers After Incomplete Radiofrequency Ablation
Liu J, Sun B, Li J, Liu X, Zhang G, Lei Z, Zheng C, Kan X
ImmunoTargets and Therapy 2025, 14:1053-1071
Published Date: 18 September 2025
Atezolizumab Plus Bevacizumab Combined with or without Transarterial Chemoembolization in the Treatment of Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Study
Li J, Bai Y, Xiong F, Liu X, Hu J, Zhang G, Liu J, Wu S, Zheng C, Kan X
Journal of Hepatocellular Carcinoma 2025, 12:973-984
Published Date: 15 May 2025
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
Zhang G, Ren Y, Liu J, Cao Y, Xiong F, Liang B, Zheng C, Kan X
Journal of Hepatocellular Carcinoma 2025, 12:15-27
Published Date: 10 January 2025
An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation
Guo Y, Ren Y, Dong X, Kan X, Zheng C
Journal of Hepatocellular Carcinoma 2022, 9:343-355
Published Date: 26 April 2022
Caudate Lobe Hepatocellular Carcinoma Treated with Sequential Transarterial Chemoembolization and Iodine 125 Seeds Implantation: A Single-Center Retrospective Study
Yan L, Chen L, Qian K, Kan X, Zhang H, Liang B, Zheng C
Cancer Management and Research 2021, 13:3901-3912
Published Date: 13 May 2021
Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome
Kan X, Wang Y, Han P, Yao Q, Qian K, Xiong B, Zheng C
Cancer Management and Research 2019, 11:7751-7757
Published Date: 15 August 2019